Cart development history
Cancer immunotherapy voted "Breakthrough of the Year Science magazine votes cancer immunotherapy the 2013 “Breakthrough of the Year.” Among the approaches discussed is CAR T cell therapy.
US reports show that CAR-T treatment of advanced acute B lymphocytic leukemia (B-ALL) 90% complete response rate in clinical studies I (complete remission for 5 years without recurrence is a clinical cure).
US President Barack Obama met Emily Whitehead - first : Child patients receiving CAR-T treatment. Emily 6 years old in Philadelphia children j The hospital received CAR-T treatment and the tumor is now fully recovered.
US time August 30, 2017, the US FDA approved Novartis :KYMRIAH listed
October 18, 201, US time, the US FDA approved the second paragraph of the world CAR-T products YESCARTA listed